[Consensus statement on the application of rTMS in depression in the Netherlands and Belgium]

Autor: M, Arns, C, Bervoets, P, van Eijndhoven, C, Baeken, O A, van den Heuvel, A, Aleman, D J L G, Schutter, Y, van der Werf, S, van Belkum, I E, Sommer, R, van Ruth, B, Haarman, J, Spijker, A T, Sack
Jazyk: Dutch; Flemish
Rok vydání: 2019
Předmět:
Zdroj: Tijdschrift voor psychiatrie. 61(6)
ISSN: 0303-7339
Popis: Since 2017, repetitive transcranial magnetic stimulation (rTMS) has become eligible for reimbursement for the treatment of therapy-resistant depression in the Dutch healthcare system.br/AIM: To initiate a guideline in the Netherlands and Belgium for the safe and effective application of rTMS for the treatment of depression.br/METHOD: Based on literature review, existing guidelines and consensus among Dutch rTMS experts, recommendations were developed regarding the implementation of rTMS as a treatment of depression. All available evidence was weighed and discussed among all co-authors and recommendations were reached by consensus among the group.br/RESULTS: rTMS targeting the dorsolateral prefrontal cortex (DLPFC) should be seen as a first choice in the treatment of depression using high-frequency rTMS (left) or, as an alternative, low-frequency rTMS (right). Stimulation protocols should use more than 1000 pulses per session for an average of 20-30 sessions, offered in 2-5 sessions per week. Contraindications for rTMS include epilepsy, intracranial presence of (magnetisable) metals, pacemaker and cochlear implant.br/CONCLUSION: rTMS, performed by competent professionals is an effective and safe treatment for depression.
Databáze: OpenAIRE